-
Mashup Score: 2Association Between Parathyroid Hormone-Related Peptide Levels and Mortality in Patients With Malignancy - 11 day(s) ago
Hypercalcemia of malignancy is a risk factor for mortality in patients with malignancies. Although the parathyroid hormone-related protein (PTHrP) secreted by tumor cells induces hypercalcemia, the association between serum PTHrP levels and mortality remains unclear. This study aimed to investigate the association between serum PTHrP levels and mortality in patients with malignancies.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6
Welcome to another issue of AACE Clinical Case Reports (ACCR). The current issue includes interesting and educational cases to share. We will provide a summary of some of those cases below. For more details, please access ACCR online journal available at https://www.aaceclinicalcasereports.com/
Source: www.aaceclinicalcasereports.comCategories: General Medicine News, EndocrinologyTweet-
The November/December 2024 issue of AACE Clinical Case Reports is now available! Read this month’s editorial for a summary of content highlights: https://t.co/U8V5drg69V @sina_jasim @Els_ENDO #endocrinology https://t.co/oNMKg3y47k
-
-
Mashup Score: 13
The goal of this review is to compare the 2024 and 2011 Endocrine Society’s Clinical Practice Guidelines on vitamin D2 or vitamin D3 (vitamin D). The 2024 Guideline made recommendations for the general healthy population for skeletal and extra skeletal health benefits of vitamin D. This contrasts with the 2011 Guidelines which provided clinicians with guidance on how to evaluate and treat patients with vitamin D deficiency and prevent recurrence.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet-
This review provides guidance for the evaluation, treatment, and prevention of vitamin D deficiency for skeletal and nonskeletal health and maintaining a circulating concentration of 25-hydroxyvitamin D of at least 30 ng/mL. Read more: https://t.co/3llOtUvLiU #EndocrinePractice… https://t.co/U4laOMDqCw https://t.co/aIjJEdjBXC
-
-
Mashup Score: 13
The goal of this review is to compare the 2024 and 2011 Endocrine Society’s Clinical Practice Guidelines on vitamin D2 or vitamin D3 (vitamin D). The 2024 Guideline made recommendations for the general healthy population for skeletal and extra skeletal health benefits of vitamin D. This contrasts with the 2011 Guidelines which provided clinicians with guidance on how to evaluate and treat patients with vitamin D deficiency and prevent recurrence.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet-
This review provides guidance for the evaluation, treatment, and prevention of vitamin D deficiency for skeletal and nonskeletal health and maintaining a circulating concentration of 25-hydroxyvitamin D of at least 30 ng/mL. Read more: https://t.co/3llOtUvLiU #EndocrinePractice… https://t.co/U4laOMDqCw https://t.co/aIjJEdjBXC
-
-
Mashup Score: 1| AACE Annual Meeting 2025 - 14 day(s) ago
The program theme: Endocrine Innovation & Obesity Breakthroughs will dive into groundbreaking approaches to metabolic disorders and obesity. Leading experts will share insights on the latest advancements in endocrine health, offering real-world solutions to improve outcomes and equity in the fight against obesity. Science is at the center of what we do, and #AACE25 is the place to be for the newest information affecting endocrinology. Catch up with old friends and meet new ones by registering today!
Source: am.aace.comCategories: General Medicine News, EndocrinologyTweet-
Registration and housing are open for the AACE Annual Meeting happening May 15-17, 2025, in Orlando, FL. Register now and save with early bird rates: https://t.co/q13GRNjta0 #AACE2025 #endocrinology https://t.co/hwP5syRM7E
-
-
Mashup Score: 0| AACE Annual Meeting 2025 - 17 day(s) ago
The program theme: Endocrine Innovation & Obesity Breakthroughs will dive into groundbreaking approaches to metabolic disorders and obesity. Leading experts will share insights on the latest advancements in endocrine health, offering real-world solutions to improve outcomes and equity in the fight against obesity. Science is at the center of what we do, and #AACE25 is the place to be for the newest information affecting endocrinology. Catch up with old friends and meet new ones by registering today!
Source: am.aace.comCategories: General Medicine News, EndocrinologyTweet-
Registration and housing are open for the AACE Annual Meeting happening May 15-17, 2025, in Orlando, FL. Register now and save with early bird rates: https://t.co/q13GRNjta0 #AACE2025 #endocrinology https://t.co/hwP5syRM7E
-
-
Mashup Score: 1
This study evaluates the relationship between the Life’s Essential 8 (LE8) scoring system and all-cause and cause-specific mortality among obese individuals using National Health and Nutrition Examination Survey data.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet-
This study validates the LE8 scoring system as a robust predictor of mortality in obese individuals, supporting its utility in clinical assessments and public health policy formulation. Read more: https://t.co/4YidFJGAKT #endocrinology @Els_ENDO @vtangpricha
-
-
Mashup Score: 3Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis - 18 day(s) ago
The risk of venous thromboembolism (VTE) with feminizing gender-affirming hormone therapy is an area of concern. This analysis aimed to assess whether gender-affirming hormone therapy and other potential risk factors are associated with VTE in transfeminine and gender diverse individuals.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet-
This analysis aimed to assess whether gender-affirming hormone therapy and other potential risk factors are associated with VTE in transfeminine and gender diverse individuals. Read more: https://t.co/i3d9rkGasg #endocrinology @Els_ENDO @vtangpricha
-
-
Mashup Score: 3Patient Journey Obesity - Homepage - 18 day(s) ago
Obesity is a complex, chronic disease of excessive or abnormally accumulated body fat, resulting in medical problems. Visit the AACE Journey for Patients With Obesity for up-to-date information, resources, and tools to navigate your diagnosis, treatment plan, and wellness goals no matter where you are in your personal journey.
Source: www.aace.comCategories: General Medicine News, EndocrinologyTweet-
As a clinician who treats patients with obesity, you may not have enough time during office visits to answer all of your patients' questions. The AACE Journey for Patients With Obesity fills the gap with trustworthy, patient-friendly info. https://t.co/dKBq9tmZdM #endotwitter
-
-
Mashup Score: 1
Read the December blog from AACE CEO Johnnie White, MBA, CAE, CMP Fellow, to catch up on impactful updates for the AACE Community. In this month’s highlights, Johnnie reflects on an incredible year at AACE.
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet-
Read the December Update from AACE CEO @johnniewhiteceo! This final blog of the year features highlights from last month and celebrates some of the key accomplishments in 2024 that exemplify the dedication and collaboration of the AACE Community. https://t.co/ociU0JjCn6… https://t.co/WhX1tZ3QfR
-
This study showed an association between PTHrP and mortality in patients with malignancy after adjusting for serum calcium levels. Read more: https://t.co/C1tYAVTEPJ #EndocrinePractice #endocrinology @vtangpricha @Els_ENDO